review article | Q7318358 |
scholarly article | Q13442814 |
P50 | author | Garth Abrahams | Q59557762 |
P2093 | author name string | Michael Hensel | |
P2860 | cites work | The intracellular fate of Salmonella depends on the recruitment of kinesin | Q24302564 |
The Salmonella effector PipB2 affects late endosome/lysosome distribution to mediate Sif extension | Q30476107 | ||
Regulation of inducible nitric oxide synthase by aggresome formation | Q33935202 | ||
Molecular basis of Salmonella-induced enteritis | Q33938202 | ||
Interaction of Salmonella enterica serotype Typhimurium with dendritic cells is defined by targeting to compartments lacking lysosomal membrane glycoproteins. | Q34004462 | ||
Identification of new secreted effectors in Salmonella enterica serovar Typhimurium | Q34033494 | ||
Taking possession: biogenesis of the Salmonella-containing vacuole | Q34221373 | ||
SpiC is required for translocation of Salmonella pathogenicity island 2 effectors and secretion of translocon proteins SseB and SseC | Q34318039 | ||
Salmonella evasion of the NADPH phagocyte oxidase | Q34469840 | ||
Trafficking of the Salmonella vacuole in macrophages | Q34557132 | ||
Phagosome maturation: aging gracefully | Q34682299 | ||
A Salmonella enterica serovar typhimurium translocated leucine-rich repeat effector protein inhibits NF-kappa B-dependent gene expression. | Q35106240 | ||
Microbial pathogenesis and cytoskeletal function. | Q35109715 | ||
Inducible nitric oxide synthase and control of intracellular bacterial pathogens | Q35145721 | ||
A conserved amino acid sequence directing intracellular type III secretion by Salmonella typhimurium | Q35162771 | ||
Immunity to Salmonella from a dendritic point of view | Q35608895 | ||
Salmonella impairs RILP recruitment to Rab7 during maturation of invasion vacuoles | Q35918621 | ||
Cellular microbiology of intracellular Salmonella enterica: functions of the type III secretion system encoded by Salmonella pathogenicity island 2. | Q35959536 | ||
Manipulation of the host actin cytoskeleton by Salmonella--all in the name of entry | Q36032340 | ||
Targeting of the actin cytoskeleton during infection by Salmonella strains | Q36049312 | ||
Molecular motors hijacking by intracellular pathogens. | Q36347858 | ||
Salmonella pathogenicity island 2 mediates protection of intracellular Salmonella from reactive nitrogen intermediates | Q36370147 | ||
SseG, a virulence protein that targets Salmonella to the Golgi network | Q39927890 | ||
Salmonella enterica serovar Typhimurium interaction with dendritic cells: impact of the sifA gene | Q40507112 | ||
Inhibition of cell surface MHC class II expression by Salmonella | Q40526235 | ||
Salmonella modulates vesicular traffic by altering phosphoinositide metabolism | Q40531614 | ||
Microtubule motors control membrane dynamics of Salmonella-containing vacuoles | Q40588868 | ||
Salmonella effectors translocated across the vacuolar membrane interact with the actin cytoskeleton | Q40658475 | ||
SpiC is required for secretion of Salmonella Pathogenicity Island 2 type III secretion system proteins. | Q40711323 | ||
Dynein-mediated vesicle transport controls intracellular Salmonella replication | Q40902794 | ||
A Salmonella virulence protein that inhibits cellular trafficking | Q40941909 | ||
The invasion-associated type III secretion system of Salmonella enterica serovar Typhimurium is necessary for intracellular proliferation and vacuole biogenesis in epithelial cells. | Q41472950 | ||
Salmonella pathogenicity island 2-encoded type III secretion system mediates exclusion of NADPH oxidase assembly from the phagosomal membrane. | Q43582908 | ||
SifA, a type III secreted effector of Salmonella typhimurium, directs Salmonella-induced filament (Sif) formation along microtubules. | Q43993314 | ||
Analysis of the mechanisms of Salmonella-induced actin assembly during invasion of host cells and intracellular replication | Q44447381 | ||
Recognition of bacteria in the cytosol of Mammalian cells by the ubiquitin system | Q44877986 | ||
Effector proteins encoded by Salmonella pathogenicity island 2 interfere with the microtubule cytoskeleton after translocation into host cells | Q47757738 | ||
The mechanism of Salmonella entry determines the vacuolar environment and intracellular gene expression. | Q50084035 | ||
Recognition of antimicrobial peptides by a bacterial sensor kinase. | Q50088065 | ||
Intracellular Salmonella inhibit antigen presentation by dendritic cells | Q50092984 | ||
Intracellular activities of Salmonella enterica in murine dendritic cells | Q50102119 | ||
Salmonella type III effectors PipB and PipB2 are targeted to detergent-resistant microdomains on internal host cell membranes | Q50103373 | ||
Remodelling of the actin cytoskeleton is essential for replication of intravacuolar Salmonella | Q50114033 | ||
Salmonella pathogenicity island 2-dependent evasion of the phagocyte NADPH oxidase | Q50122203 | ||
T-cell engagement of dendritic cells rapidly rearranges MHC class II transport. | Q54026692 | ||
P433 | issue | 5 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | Salmonella enterica | Q2264864 |
P304 | page(s) | 728-737 | |
P577 | publication date | 2006-05-01 | |
P1433 | published in | Cellular Microbiology | Q1921948 |
P1476 | title | Manipulating cellular transport and immune responses: dynamic interactions between intracellular Salmonella enterica and its host cells | |
P478 | volume | 8 |
Q27349443 | A Salmonella small non-coding RNA facilitates bacterial invasion and intracellular replication by modulating the expression of virulence factors |
Q94446947 | An alternative penicillin-binding protein involved in Salmonella relapses following ceftriaxone therapy |
Q33747798 | An incomplete TCA cycle increases survival of Salmonella Typhimurium during infection of resting and activated murine macrophages |
Q39015437 | An oral vaccine for type 1 diabetes based on live attenuated Salmonella. |
Q27319404 | Analysis of cells targeted by Salmonella type III secretion in vivo |
Q33584937 | Control of Salmonella pathogenicity island-2 gene expression |
Q37318603 | Culling of activated CD4 T cells during typhoid is driven by Salmonella virulence genes. |
Q33634073 | Curcumin increases the pathogenicity of Salmonella enterica serovar Typhimurium in murine model |
Q39296439 | Deletions in the pyruvate pathway of Salmonella Typhimurium alter SPI1-mediated gene expression and infectivity |
Q54393542 | Detection of type III secretion gene as an indicator for pathogenic Edwardsiella tarda. |
Q33928888 | Differential expression of Salmonella type III secretion system factors InvJ, PrgJ, SipC, SipD, SopA and SopB in cultures and in mice |
Q35071000 | Direct visualization of endogenous Salmonella-specific B cells reveals a marked delay in clonal expansion and germinal center development |
Q41909266 | Dormant intracellular Salmonella enterica serovar Typhimurium discriminates among Salmonella pathogenicity island 2 effectors to persist inside fibroblasts. |
Q40046693 | During infection of epithelial cells Salmonella enterica serovar Typhimurium undergoes a time-dependent transcriptional adaptation that results in simultaneous expression of three type 3 secretion systems |
Q30524361 | Dynamics of Salmonella infection of macrophages at the single cell level. |
Q44388355 | Effect of sublethal heat stress on Salmonella Typhimurium virulence |
Q34438443 | Effective cancer vaccine platform based on attenuated salmonella and a type III secretion system |
Q41693564 | Esteya Vermicola, a Nematophagous Fungus Attacking the Pine Wood Nematode, Harbors a Bacterial Endosymbiont Affiliated with Gammaproteobacteria |
Q35805445 | Evaluation of Salmonella enterica type III secretion system effector proteins as carriers for heterologous vaccine antigens |
Q31057539 | Functional dissection of SseF, a membrane-integral effector protein of intracellular Salmonella enterica |
Q50079368 | Functional dissection of SseF, a type III effector protein involved in positioning the salmonella-containing vacuole. |
Q50073070 | Gene expression response of the rat small intestine following oral Salmonella infection |
Q39185471 | Global impact of Salmonella pathogenicity island 2-secreted effectors on the host phosphoproteome. |
Q92726074 | Global transcriptomic analyses of Salmonella enterica in Iron-depleted and Iron-rich growth conditions |
Q37256563 | Glucose and glycolysis are required for the successful infection of macrophages and mice by Salmonella enterica serovar typhimurium. |
Q37012231 | Host-pathogen interplay and the evolution of bacterial effectors |
Q43184076 | Identification of novel genes and pathways affecting Salmonella type III secretion system 1 using a contact-dependent hemolysis assay |
Q33788711 | Immunity to intestinal pathogens: lessons learned from Salmonella |
Q38741409 | Influence of Salmonella enterica serovar Pullorum pathogenicity island 2 on type III secretion system effector gene expression in chicken macrophage HD11 cells |
Q40063549 | Innate immune responses of gingival epithelial cells to nonperiodontopathic and periodontopathic bacteria |
Q35090110 | Interaction of Salmonella spp. with the Intestinal Microbiota |
Q38793052 | Intestinal innate immunity and the pathogenesis of Salmonella enteritis |
Q33675489 | Involvement of TIP60 acetyltransferase in intracellular Salmonella replication |
Q91838920 | Lactic acid bacteria decrease Salmonella enterica Javiana virulence and modulate host inflammation during infection of an intestinal epithelial cell line |
Q37612560 | Life in the inflamed intestine, Salmonella style |
Q40626142 | Long-term live-cell imaging reveals new roles for Salmonella effector proteins SseG and SteA. |
Q89537685 | Molecular Mechanisms of Salmonella Effector Proteins: A Comprehensive Review |
Q31079248 | Molecular insights into farm animal and zoonotic Salmonella infections |
Q34729956 | Morphological plasticity as a bacterial survival strategy |
Q41639218 | Nanocapsules loaded with iron-saturated bovine lactoferrin have antimicrobial therapeutic potential and maintain calcium, zinc and iron metabolism |
Q34357503 | Novel cancer vaccine based on genes of Salmonella pathogenicity island 2. |
Q35163250 | Nutritional and metabolic requirements for the infection of HeLa cells by Salmonella enterica serovar Typhimurium |
Q35666065 | Oral Delivery of a Novel Attenuated Salmonella Vaccine Expressing Influenza A Virus Proteins Protects Mice against H5N1 and H1N1 Viral Infection |
Q64062969 | Outer Protein B Suppresses Colitis Development via Protecting Cell From Necroptosis |
Q35598110 | Palmitoylation state impacts induction of innate and acquired immunity by the Salmonella enterica serovar typhimurium msbB mutant |
Q35080995 | Population dynamics of Salmonella enterica serotypes in commercial egg and poultry production |
Q40062098 | Protein Acetylation Is Involved in Salmonella enterica Serovar Typhimurium Virulence |
Q35745541 | Proteomic Analyses of Intracellular Salmonella enterica Serovar Typhimurium Reveal Extensive Bacterial Adaptations to Infected Host Epithelial Cells |
Q37274847 | Proteomic investigation of the time course responses of RAW 264.7 macrophages to infection with Salmonella enterica |
Q24302123 | Quantitative mass spectrometry catalogues Salmonella pathogenicity island-2 effectors and identifies their cognate host binding partners |
Q61809795 | Role of CsrA in stress responses and metabolism important for Salmonella virulence revealed by integrated transcriptomics |
Q34747098 | Role of Hcp, a type 6 secretion system effector, of Aeromonas hydrophila in modulating activation of host immune cells |
Q37287154 | Salmonella Infection Enhances Erythropoietin Production by the Kidney and Liver, Which Correlates with Elevated Bacterial Burdens |
Q34558189 | Salmonella SPI-1-mediated neutrophil recruitment during enteric colitis is associated with reduction and alteration in intestinal microbiota |
Q37970705 | Salmonella enterica as a vaccine carrier. |
Q26999425 | Salmonella pathogenicity and host adaptation in chicken-associated serovars |
Q34377752 | Salmonella pathogenicity island 2 expression negatively controlled by EIIANtr-SsrB interaction is required for Salmonella virulence. |
Q30480354 | Salmonella trafficking is defined by continuous dynamic interactions with the endolysosomal system. |
Q37099431 | Salmonella-containing vacuoles display centrifugal movement associated with cell-to-cell transfer in epithelial cells. |
Q27675137 | Structure of the catalytic domain of theSalmonellavirulence factor SseI |
Q41775111 | Systematic analysis of the SsrAB virulon of Salmonella enterica |
Q33877264 | Taming the elephant: Salmonella biology, pathogenesis, and prevention |
Q34139977 | Temporal expression of bacterial proteins instructs host CD4 T cell expansion and Th17 development |
Q40319960 | The Role of the spv Genes in Salmonella Pathogenesis |
Q30480339 | The SPI-2 type III secretion system restricts motility of Salmonella-containing vacuoles |
Q35037325 | The Salmonella effector protein PipB2 is a linker for kinesin-1 |
Q36961170 | The Salmonella-containing vacuole: moving with the times |
Q36411013 | The Stringent Response Regulator DksA Is Required for Salmonella enterica Serovar Typhimurium Growth in Minimal Medium, Motility, Biofilm Formation, and Intestinal Colonization |
Q33603111 | The iron-sensing fur regulator controls expression timing and levels of salmonella pathogenicity island 2 genes in the course of environmental acidification |
Q40468478 | The translocated Salmonella effector proteins SseF and SseG interact and are required to establish an intracellular replication niche. |
Q40974806 | Toward an optimized treatment of intracellular bacterial infections: input of nanoparticulate drug delivery systems |
Q27334132 | Transcriptional priming of Salmonella Pathogenicity Island-2 precedes cellular invasion |
Q93173167 | ptsI gene in the phosphotransfer system is a potential target for developing a live attenuated Salmonella vaccine |
Search more.